ANDA 74914, held by Teva Pharms. Acyclovir.
As of Nov 13, 2026, ANDA 74914 (Acyclovir), held by Teva Pharms, was first approved by FDA on Nov 26, 1997, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 26, 1997 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acyclovir200MG ยท capsule;oral | Acyclovir | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 23, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Nov 26, 1997 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
